BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Liver
,
Neocentromeres
,
Clofibrate
,
rs2300478
,
PRKCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Fibrodysplasia Ossificans Progressiva
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
ACVR1
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
endocardial cushion cell fate commitment
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation
cell adhesion involved in heart morphogenesis
BMP signaling pathway involved in heart development
GS domain
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
OMIM - Fibrodysplasia ossificans progressiva
OMIM - Congenital disorder
Explore Curated Studies Results
Literature
Most Relevant Literature
Recommendations for the healthcare of patients with FOP].
BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP).
Use of Enrofloxacin and Hydrotherapy in the Management of Fibrodysplasia Ossificans Progressiva (FOP…
Novel Therapeutic Targets for Fibrodysplasia Ossificans Progressiva: Emerging Strategies and Future …
Faces of Fibrodysplasia Ossificans Progressiva: Lessons from a Clinical Masquerader.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progress…
Study to Assess the Efficacy and Safety of 2 Dosage Regimens of Oral IPN60130 for the Treatment of F…
An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FO…
A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)
To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia O…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ